@jeanconnorsmd.bsky.social
Connected with @pamchmd while at @acc25. Former Boston heme fellow now Chicago attending
March 30, 2025 at 8:57 PM
Connected with @pamchmd while at @acc25. Former Boston heme fellow now Chicago attending
March 29, 2025 at 6:21 PM
@acc25.bsky.social Isabelle Mahe presents API-CAT
Low dose Apixaban noninferior to high dose for recurrent VTE and superior for lower bleeding-another win!
Low dose Apixaban noninferior to high dose for recurrent VTE and superior for lower bleeding-another win!
March 29, 2025 at 3:34 PM
@acc25.bsky.social Isabelle Mahe presents API-CAT
Low dose Apixaban noninferior to high dose for recurrent VTE and superior for lower bleeding-another win!
Low dose Apixaban noninferior to high dose for recurrent VTE and superior for lower bleeding-another win!
ACC25 Mark Bonaca presenting onsemiglutide on pad improvement in the STRIDE trial—clear success
March 29, 2025 at 3:09 PM
ACC25 Mark Bonaca presenting onsemiglutide on pad improvement in the STRIDE trial—clear success
At my local @uspsopsanta.bsky.social @uspshelp.bsky.social
December 21, 2024 at 10:25 PM
At my local @uspsopsanta.bsky.social @uspshelp.bsky.social
#ASH24 Coag Community reception w @marycushmanmd.bsky.social Long Zheng, Cheryl Maier, and Gary Gilbert. thanks American Society of Hematology!
December 10, 2024 at 4:33 PM
#ASH24 Coag Community reception w @marycushmanmd.bsky.social Long Zheng, Cheryl Maier, and Gary Gilbert. thanks American Society of Hematology!
